ScoreWhy is TherapeuticsMD, Inc. ?
1
With a growth in Net Sales of 142.24%, the company declared Very Positive results in Jun 25
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(HY) At USD 1.34 MM has Grown at 145.89%
- RAW MATERIAL COST(Y) Fallen by -302.72% (YoY)
- DEBTORS TURNOVER RATIO(HY) Highest at 0.77 times
2
With ROE of -2.93%, it has a risky valuation with a 0.54 Price to Book Value
- Over the past year, while the stock has generated a return of 16.55%, its profits have risen by 87.4%
3
High Institutional Holdings at 31.79%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to TherapeuticsMD, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is TherapeuticsMD, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
TherapeuticsMD, Inc.
19.67%
-0.18
122.47%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-46.42%
EBIT Growth (5y)
14.68%
EBIT to Interest (avg)
-4.73
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.47
Tax Ratio
2.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
31.79%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.54
EV to EBIT
-3.11
EV to EBITDA
-3.66
EV to Capital Employed
0.44
EV to Sales
5.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.24%
ROE (Latest)
-2.93%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend28What is working for the Company
NET SALES(HY)
At USD 1.34 MM has Grown at 145.89%
RAW MATERIAL COST(Y)
Fallen by -302.72% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 0.77 times
PRE-TAX PROFIT(Q)
Highest at USD 0.55 MM
NET PROFIT(Q)
Highest at USD 0.55 MM
EPS(Q)
Highest at USD 0.05
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for TherapeuticsMD, Inc.
Net Sales
At USD 1.34 MM has Grown at 145.89%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 0.55 MM has Grown at 357.68%
over average net sales of the previous four periods of USD -0.21 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.55 MM has Grown at 378.42%
over average net sales of the previous four periods of USD -0.2 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Pre-Tax Profit
Highest at USD 0.55 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 0.55 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.05
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 0.77 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -302.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
